Author:
Rolandsson Enes Sara,Andersson Sjöland Annika,Skog Ingrid,Hansson Lennart,Larsson Hillevi,Le Blanc Katarina,Eriksson Leif,Bjermer Leif,Scheding Stefan,Westergren-Thorsson Gunilla
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Tzouvelekis, A. et al. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med 11, 171, 10.1186/1479-5876-11-171 (2013).
2. Weiss, D. J., Casaburi, R., Flannery, R., LeRoux-Williams, M. & Tashkin, D. P. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 143, 1590–1598, 10.1378/chest.12-2094 (2013).
3. Simonson, O. E. et al. In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome. Stem Cells Transl Med, 10.5966/sctm.2015-0021 (2015).
4. Estenne, M. & Hertz, M. I. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 166, 440–444 (2002).
5. Rolandsson, S. et al. Primary mesenchymal stem cells in human transplanted lungs are CD90/CD105 perivascularly located tissue-resident cells. BMJ open respiratory research 1, e000027, 10.1136/bmjresp-2014-000027 (2014).
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献